Acetylation of p65 at lysine 314 is important for late NF-κB-dependent gene expression

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Rothgiesser, Karin M ^a   Fey, Monika ^a   Hottiger, Michael O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; STROMELYSIN 2; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR RELA;

ACETYLATION; ANIMAL TISSUE; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN MODIFICATION; REGULATORY MECHANISM; UNINDEXED SEQUENCE; ANIMAL; CELL STRAIN 3T3; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MOUSE; PROTEIN PROCESSING;

ACETYLATION; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LYSINE; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 13; MICE; MUTATION; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76949098761     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-22     Document Type: Article

References (29)

1. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-96. 10.1016/S0092-8674(02)00703-1, 11983155.
2. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25(6):280-288. 10.1016/j.it.2004.03.008, 15145317.
3. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 2006, 25(51):6706-6716. 10.1038/sj.onc.1209933, 17072323.
4. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18(49):6853-6866. 10.1038/sj.onc.1203239, 10602461.
5. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappaB system: a treasure trove for drug development. Nat Rev Drug Discov 2004, 3(1):17-26. 10.1038/nrd1279, 14708018.
6. Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006, 25(51):6717-6730. 10.1038/sj.onc.1209937, 17072324.
7. Vermeulen L, De Wilde G, Van Damme P, Berghe W, Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 2003, 22(6):1313-1324. 10.1093/emboj/cdg139, 151081, 12628924.
8. Saccani S, Marazzi I, Beg AA, Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 2004, 200(1):107-113. 10.1084/jem.20040196, 2213320, 15226358.
9. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003, 12(6):1413-1426. 10.1016/S1097-2765(03)00490-8, 14690596.
10. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002, 9(3):625-636. 10.1016/S1097-2765(02)00477-X, 11931769.
11. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998, 1(5):661-671. 10.1016/S1097-2765(00)80066-0, 9660950.
12. Duran A, Diaz-Meco MT, Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 2003, 22(15):3910-3918. 10.1093/emboj/cdg370, 169043, 12881425.
13. Chew J, Biswas S, Shreeram S, Humaidi M, Wong ET, Dhillion MK, Teo H, Hazra A, Fang CC, Lopez-Collazo E, et al. WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat Cell Biol 2009, 11(5):659-666. 10.1038/ncb1873, 19377466.
14. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001, 293(5535):1653-1657. 10.1126/science.1062374, 11533489.
15. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003, 278(4):2758-2766. Epub 2002 Nov 2704, 10.1074/jbc.M209572200, 12419806.
16. Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, Kashanchi F. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J Biol Chem 2002, 277(7):4973-4980. 10.1074/jbc.M107848200, 11739381.
17. Ishinaga H, Jono H, Lim JH, Kweon SM, Xu H, Ha UH, Koga T, Yan C, Feng XH, Chen LF, et al. TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J 2007, 26(4):1150-1162. 10.1038/sj.emboj.7601546, 1852843, 17268554.
18. Buerki C, Rothgiesser KM, Valovka T, Owen HR, Rehrauer H, Fey M, Lane WS, Hottiger MO. Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Res 2008, 36(5):1665-1680. 10.1093/nar/gkn003, 2275151, 18263619.
19. Huang Y, Krein PM, Muruve DA, Winston BW. Complement factor B gene regulation: synergistic effects of TNF-alpha and IFN-gamma in macrophages. J Immunol 2002, 169(5):2627-2635.
20. Apostolou E, Thanos D. Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Cell 2008, 134(1):85-96. 10.1016/j.cell.2008.05.052, 18614013.
21. Teferedegne B, Green MR, Guo Z, Boss JM. Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol Cell Biol 2006, 26(15):5759-5770. 10.1128/MCB.00271-06, 1592769, 16847329.
22. George AA, Sharma M, Singh BN, Sahoo NC, Rao KV. Transcription regulation from a TATA and INR-less promoter: spatial segregation of promoter function. EMBO J 2006, 25(4):811-821. 10.1038/sj.emboj.7600966, 1383549, 16437157.
23. Muddasani P, Norman JC, Ellman M, van Wijnen AJ, Im HJ. Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 2007, 282(43):31409-31421. 10.1074/jbc.M706508200, 17724016.
24. Mujtaba S, Zeng L, Zhou MM. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 2007, 26(37):5521-5527. 10.1038/sj.onc.1210618, 17694091.
25. Latham JA, Dent SY. Cross-regulation of histone modifications. Nat Struct Mol Biol 2007, 14(11):1017-1024. 10.1038/nsmb1307, 17984964.
26. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 2009, 28(8):1055-1066. 10.1038/emboj.2009.55, 19262565.
27. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376(6536):167-170. 10.1038/376167a0, 7603567.
28. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 2003, 278(46):45145-45153. 10.1074/jbc.M307957200, 12960163.
29. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30(9):e36. 10.1093/nar/30.9.e36, 113859, 11972351.